> top > docs > PubMed:32282022 > spans > 780-954 > annotations

PubMed:32282022 / 780-954 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T19 0-10 DG_28 denotes Remdesivir
T20 48-58 SP_7 denotes SARS-CoV-2
T21 86-90 CHEBI:23888 denotes Drug
T22 86-90 CHEBI:23888 denotes Drug

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T11 48-56 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T4 11-14 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T5 31-39 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T6 138-144 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
32 0-10 Chemical denotes Remdesivir MESH:C000606551
33 48-58 Species denotes SARS-CoV-2 Tax:2697049

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T10 0-174 Sentence denotes Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials.